Limitations, agreements, and source contact

Radiation Therapy and Cetuximab in Treating Patients With Recurrent Head and Neck Cancer · Source last updated 2016-04-14

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

limitations And Caveats

description

Trial terminated early. Too few patients to analyze.

point Of Contact

organization

Roswell Park Cancer Institute

phone

716-845-2300

title

Senior Administrator, Compliance - Clinical Research Services

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice